The Department of Medicine is one of the largest teaching and research organisations in the UK, with a reputation for excellence and a vibrant and international working community. The department has a grant income of over £60m.
Professor Martin Wilkins, Professor of Clinical Pharmacology, Head of the Division of Experimental Medicine, has accepted the appointment as the interim Head of Department of Medicine within the Faculty of Medicine for 12 months from 1 December 2013. Professor Wilkins is a clinician scientist with a background in clinical pharmacology and toxicology. His primary interest is in proof-of-concept studies in humans. He uses pulmonary hypertension as a paradigm for developing novel therapies from the laboratory to patients. He has recently stepped down from his role a director of a major clinical program group in the Trust. He is the Director of the National Institute for Health Research/Wellcome Trust Clinical Research Facility [formerly the Sir John McMichael Centre] and Director of the Wellcome Trust’s Translational Medicine Fellowship Training Programme. He is President of the Pulmonary Vascular Research Institute, a Fellow of The British Pharmacology Society, Chairman of the BHF Fellowships Committee and Visiting Professor at ChaoYang Hospital in Beijing. He will succeed Professor Gavin Screaton who has led the Department of Medicine since 1 January 2009. Professor Screaton has been seconded from his role as Head of Department to devote his full efforts to co-ordination of Faculty planning activities in his new role of Vice Dean (Academic Development).